Literature DB >> 3783836

Tuberculous aortitis with associated necrosis and perforation: treatment and options.

J S Cargile, D F Fisher, D K Burns, W J Fry.   

Abstract

Tuberculous aortitis is a rare entity and its association with necrosis and perforation is even more unusual. Our pulmonary medicine service originally evaluated an elderly woman with a right pleural effusion and upper lobe infiltrate thought to be tuberculosis. An abdominal CT scan performed at that time showed extensive periaortic adenopathy. Isoniazid and rifampin were started, but both were stopped by the patient after less than 6 months of therapy. The patient later had night sweats, a left pleural effusion, and a tender abdominal mass thought to be a symptomatic aneurysm. At operation, the aorta was necrotic and had an inflammatory mass and perforation on the left side. Infrarenal aortic ligation and resection were performed to control infection. A previously placed axillofemoral graft obviated the need for concomitant revascularization. The patient was treated postoperatively with isoniazid and rifampin until hyperbilirubinemia developed, which necessitated alternate therapy with ethambutol and streptomycin. The patient died one month after operation of a presumed pulmonary embolus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783836

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

1.  Tuberculous aneurysm of the abdominal aorta: endovascular repair using stent grafts in two cases.

Authors:  W C Liu; B K Kwak; K N Kim; S Y Kim; J J Woo; D J Chung; J H Hong; H S Kim; C J Lee; H J Shim
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

2.  A case series of surgically diagnosed idiopathic aortitis in a Canadian centre: a retrospective study.

Authors:  Diane L Murzin; Eric C Belanger; John P Veinot; Nataliya Milman
Journal:  CMAJ Open       Date:  2017-06-19

3.  Tuberculous aortitis.

Authors:  Zakeya A Bukhary; Abdulrahman A Alrajhi
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.